249 related articles for article (PubMed ID: 23664125)
21. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.
Morris MD; Evans J; Montgomery M; Yu M; Briceno A; Page K; Hahn JA
PLoS One; 2014; 9(10):e109282. PubMed ID: 25286346
[TBL] [Abstract][Full Text] [Related]
22. HIV risk and the overlap of injecting drug use and high-risk sexual behaviours among men who have sex with men in Zanzibar (Unguja), Tanzania.
Johnston LG; Holman A; Dahoma M; Miller LA; Kim E; Mussa M; Othman AA; Kim A; Kendall C; Sabin K
Int J Drug Policy; 2010 Nov; 21(6):485-92. PubMed ID: 20638262
[TBL] [Abstract][Full Text] [Related]
23. Acquiring hepatitis C in prison: the social organisation of injecting risk.
Treloar C; McCredie L; Lloyd AR;
Harm Reduct J; 2015 Apr; 12():10. PubMed ID: 25903401
[TBL] [Abstract][Full Text] [Related]
24. [Widespread risk behavior among injecting drug users. Over 80 percent HCV-infected--7 percent have HIV, as demonstrated by the first baseline study].
Hillgren K; Sarkar K; Elofsson S; Britton S
Lakartidningen; 2012 Jun 19-26; 109(25):1221-5. PubMed ID: 22838111
[No Abstract] [Full Text] [Related]
25. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
[TBL] [Abstract][Full Text] [Related]
26. More than just someone to inject drugs with: Injecting within primary injection partnerships.
Morris MD; Bates A; Andrew E; Hahn J; Page K; Maher L
Drug Alcohol Depend; 2015 Nov; 156():275-281. PubMed ID: 26460140
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
Falster K; Kaldor JM; Maher L;
J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
[TBL] [Abstract][Full Text] [Related]
28. Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships.
Morris MD; Andrew E; Tan JY; Maher L; Hoff C; Darbes L; Page K
PLoS One; 2019; 14(5):e0217811. PubMed ID: 31150518
[TBL] [Abstract][Full Text] [Related]
29. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
[TBL] [Abstract][Full Text] [Related]
30. Change in injecting behaviour among people treated for hepatitis C virus: The role of intimate partnerships.
Malaguti A; Sani F; Stephens BP; Ahmad F; Dugard P; Dillon JF;
J Viral Hepat; 2019 Jan; 26(1):65-72. PubMed ID: 30260560
[TBL] [Abstract][Full Text] [Related]
31. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
Deryabina AP; Patnaik P; El-Sadr WM
Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
[TBL] [Abstract][Full Text] [Related]
32. Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors.
Brewer DD; Hagan H; Sullivan DG; Muth SQ; Hough ES; Feuerborn NA; Gretch DR
J Infect Dis; 2006 Sep; 194(6):764-72. PubMed ID: 16941342
[TBL] [Abstract][Full Text] [Related]
33. Male IDUs who have sex with men in England, Wales and Northern Ireland: are they at greater risk of bloodborne virus infection and harm than those who only have sex with women?
Marongiu A; Hope VD; Parry JV; Ncube F
Sex Transm Infect; 2012 Oct; 88(6):456-61. PubMed ID: 22628667
[TBL] [Abstract][Full Text] [Related]
34. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming.
Baluku M; Wamala T; Muhangi D
Harm Reduct J; 2019 Sep; 16(1):56. PubMed ID: 31481086
[TBL] [Abstract][Full Text] [Related]
35. A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners.
Morris MD; Montgomery ME; Briceno A; Evans JL; Andrew EVW; Page K; Hahn JA
Subst Use Misuse; 2018 Jul; 53(8):1281-1287. PubMed ID: 29286888
[TBL] [Abstract][Full Text] [Related]
36. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting.
Lafferty L; Rance J; Treloar C
Drug Alcohol Depend; 2018 Feb; 183():96-101. PubMed ID: 29245104
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users.
Robinson GM; Reynolds JN; Robinson BJ
N Z Med J; 1995 Mar; 108(996):103-5. PubMed ID: 7715873
[TBL] [Abstract][Full Text] [Related]
38. The relative risk of HIV among IDUs not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
AIDS Care; 2009 Aug; 21(8):984-91. PubMed ID: 20024754
[TBL] [Abstract][Full Text] [Related]
39. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
[TBL] [Abstract][Full Text] [Related]
40. Intra-couple communication dynamics of HIV risk behavior among injecting drug users and their sexual partners in Northern Vietnam.
Go VF; Quan VM; Voytek C; Celentano D; Nam le V
Drug Alcohol Depend; 2006 Sep; 84(1):69-76. PubMed ID: 16413145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
